Unlocked Labs

08/15/2024

It's Officially Official!!
The long-awaited three letters that make it real - NoA - Notice of Award!

This morning, Unlocked Labs received a Notice of Award from the National Institutes of Health for our SBIR Phase II grant, totaling $1.88M. This grant is a testament to our team’s hard work and success! During Phase I, we developed OX164, our groundbreaking probiotic lead strain for a single purpose – to digest dietary oxalate. By breaking down oxalate in the GI tract, our probiotic is designed to help reduce urinary oxalate - a key component of 75% of kidney stones.

This Phase II SBIR grant will fund R&D to deepen our understanding of the performance of strain OX164 as it moves through the digestive system. It will also bring us closer to delivering this impactful solution by supporting the development of a robust production process and a comprehensive safety dossier. Finally, our goal is to demonstrate efficacy in an animal model.

This is a collective win for the entire team, and it wouldn’t have been possible without everyone’s hard work and dedication. Thanks also to our investors for believing in us, for funding Unlocked, and for their generosity in sharing their time and connections!

Stay updated on our progress by visiting our website (unlocked.bio) and following us on LinkedIn!

- Team Unlocked

06/06/2022

We are happy to announce our new addition to the team, Caleb Price. Caleb recently graduated from the University of Wyoming, with a B.S. in Chemical Engineering and Molecular Biology. As a Research Assistant, he will help accelerate our R&D. Join us in congratulating Caleb on his recent graduation and new role at Unlocked Labs!

02/01/2022

60 days in the IndieBio program – the assignment was to put together a 2:30 video describing our company. We really liked the outcome and wanted to share it with you. Tell us what you think!

01/26/2022

We are excited to announce that Michal Luczak will be joining the unlocked labs' team as our Head of Detoxification! Before joining the unlocked labs, Michal was an Assistant Professor of Pathology and Laboratory Medicine at Brown University. His experience and knowledge will be invaluable assets as we strive to revolutionize the world of probiotics.

01/14/2022

TechCrunch featured unlocked labs as one of the 13 startups in IndieBio's SF batch. Let's go!

It’s been a big two years for biotech investors. But if you ask Po Bronson, a partner at SOSV’s IndieBio, this trend was probably a long time coming. “Often, the implication is that everything must be overpriced,” he tells TechCrunch. “But I think more of it is that some major theses in th...

12/28/2021

We’ve been hard at work this fall and winter, so we haven't posted much lately. However, we’re THRILLED to finally announce that Theraneutrics was accepted into the IndieBio accelerator program in San Francisco!! This has been a dream of ours for a long time, and it's a bit surreal to finally be a part of this incredible community of biotech pioneers. It's going to be an intense next few months, but we’re looking forward to it!

We’re looking to hire a scientist – if you know someone with experience in genetic engineering who’s excited to work with us on developing probiotics designed to solve chronic conditions, send them our way!

10/01/2021

Pharma's Almanac is on the road to interview innovative companies about their mission and the future of biotechnology. Theraneutrics proudly represented Wyoming! We'll post a link to the video as soon as it's available - stay tuned!